Alphina Therapeutics Funding: $40M Raised, Series A (2021)
Alphina Therapeutics is based in New Haven. It has raised $40M in total funding. Latest round: Series A.
Alphina Therapeutics funding overview
Alphina Therapeutics is based in New Haven. Alphina Therapeutics has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2021. The round record for Alphina Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Canaan Partners, Osage University Partners, Connecticut Innovations, HighCape Partners, Alexandria Venture Investments. 5 distinct backers are named across the disclosed rounds.
Frequently asked about Alphina Therapeutics funding
How much has Alphina Therapeutics raised?
Alphina Therapeutics has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Alphina Therapeutics?
Canaan Partners, Osage University Partners, Connecticut Innovations, HighCape Partners, Alexandria Venture Investments are named among the investors backing Alphina Therapeutics.
What was the latest Alphina Therapeutics funding round?
The most recent disclosed round is a Series A, announced in September 2021.
Where is Alphina Therapeutics based?
Alphina Therapeutics is based in New Haven.
When did Alphina Therapeutics last raise?
The last disclosed Alphina Therapeutics round closed in September 2021 at Series A.
Round data for Alphina Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in New Haven and backer lists below.
